Northland Pharmaceuticals: Phase IIc Clinical Trial Protocol for NL005 Finalized; Addresses Unmet Global Need in Myocardial Reperfusion Injury

Source: Cailian Press

【NorthlandNL005 Project Phase IIc Clinical Trial Protocol Basically Confirmed: No Effective Treatment Drugs Available Worldwide in This Field